Brief: Longbio Pharma (Suzhou)Says Phase III Trial Of LP-3 For Seasonal Allergic Rhinitis Meets Primary Endpoints12/06/2026 02:36
Last trade - 00:00Last trade - 00:00Last trade - 00:00